about
Problems monitoring response in multiple myelomaArterial thrombosis in four patients treated with thalidomideManagement of thalidomide toxicity.Advances in the treatment of multiple myeloma: the role of thalidomide.Thalidomide: a new anticancer drug?Thalidomide and its derivatives: new promise for multiple myeloma.Bortezomib treatment for multiple myeloma.Cure of myeloma: hype or reality?Role of allogeneic stem cell transplantation in multiple myeloma.miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1TNF-α, a good or bad factor in hematological diseases?Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.A preliminary study of the effect of curcumin on the expression of p53 protein in a human multiple myeloma cell line.Transplantation as salvage therapy for high-risk patients with myeloma in relapse.99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients.Thalidomide and thrombosis in multiple myeloma.Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation.
P2860
Q24676888-EEB5AD6D-4912-4EC9-803C-BD17B692AB05Q28212339-30D16623-11DC-400B-9DEA-9E92153EB271Q34343991-41FE2D3B-B968-4609-814D-C330F838FBA0Q35104386-1AE05761-CF70-4673-B1B0-004B80848DEFQ35164773-5C472C1F-D488-4E5D-93AC-719B395C81FCQ35569462-2499FA55-B217-4910-87E7-938707709F3DQ35590997-74407A4D-6BB8-4A67-9711-8E88247EAAFEQ35949091-8F022922-B4BA-44F9-942A-0F3306CF4F20Q36185617-3C07DDA5-45AE-4D09-A9C3-3FC9C12F3E66Q36525161-0F25FD23-3841-4E10-BF8B-EAABF06AD2A5Q37043776-63CE3351-1CFE-485F-B095-A88E165F4E95Q38353590-EBB95BAF-C31B-4929-9998-B4EAE7625051Q38897664-BB02A702-F536-4DA5-8CAA-A00A564211ACQ44245114-E0D1537D-2D2B-4B99-929D-7D9C1D3AD1E3Q44509240-0AE2A51A-FC83-4AB4-97B6-81EFA5C3FAAFQ44518870-9F2D298C-55C8-4DDA-B868-6729D1DFA865Q50762331-4E2F76D7-9DC7-4EAC-954A-AC3F22FD7AB7
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Thalidomide in the management of multiple myeloma.
@ast
Thalidomide in the management of multiple myeloma.
@en
Thalidomide in the management of multiple myeloma.
@nl
type
label
Thalidomide in the management of multiple myeloma.
@ast
Thalidomide in the management of multiple myeloma.
@en
Thalidomide in the management of multiple myeloma.
@nl
prefLabel
Thalidomide in the management of multiple myeloma.
@ast
Thalidomide in the management of multiple myeloma.
@en
Thalidomide in the management of multiple myeloma.
@nl
P2093
P1476
Thalidomide in the management of multiple myeloma.
@en
P2093
Anaissie E
Barlogie B
P304
P356
10.1016/S0037-1963(01)90017-4
P577
2001-07-01T00:00:00Z